Aug 2021
STATE COLLEGE, Pa., Aug. 30, 2021 /PRNewswire/ -- NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company
Mar 2020
Nature Communications Publication Demonstrates Proof of Principle for Neuroregenerative Approach Pioneered by Founder and Chief Scientific Officer of NeuExcell Therapeutics
Sep 2019
It's a race against time when someone suffers a stroke caused by a blockage of a blood vessel supplying the brain.